Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, Guttierez M, Levine P, Magrath I
Pediatric Branch, National Cancer Institute, Bethesda, MD 20892.
Blood. 1991 Apr 1;77(7):1516-26.
We have examined, by Southern blotting, the patterns of chromosomal breakpoint locations in 55 cases of Burkitt's lymphoma (BL) with respect to geography and Epstein-Barr virus (EBV) association. We have confirmed the association between chromosome 8 breakpoint and geography: 74% of endemic (eBL) but only 9% of sporadic BL (sBL) had breakpoints outside the HindIII fragment encompassing the c-myc gene (P2 less than .00001). Conversely, not only did 91% of sBL manifest a rearranged HindIII fragment, but at least 56% of these cases, in contrast to 17% of eBL cases, had a breakpoint within the first exon or intron of c-myc (P2 less than .004). Breakpoints outside the switch mu (S mu) region (ie, the HindIII fragment encompassing S mu) on chromosome 14 were twice as common overall (73%) as those within S mu (27%), but in the 15 tumors with S mu breakpoints, 13 (87%) had a rearranged c-myc gene. Breakpoints outside the HindIII fragment encompassing c-myc on chromosome 8 were predominantly associated with non-S mu breakpoints on chromosome 14 (85%) and this was the combination most frequently associated with eBL (65%; 6% of sBL, P2 less than .00001). In sBL, the most frequent breakpoint combination was a rearranged c-myc gene with a non-S mu breakpoint (63%; 13% of eBL). Twenty-eight percent of sBL and 13% of eBL had breakpoints both within c-myc and within S mu. EBV DNA was present in 19 of 20 tumors with breakpoints outside c-myc, in none of 7 with a breakpoint in the immediate 5' region of c-myc, in 4 of 5 tumors with breakpoints in the first exon, and in 7 of 12 tumors with breakpoints in the first intron. These data suggest that the pathogeneses of eBL and sBL differ with regard to the mechanism of c-myc deregulation, and probably also with regard to the state of differentiation of the target cell for malignant transformation. We have formulated a testable hypothesis regarding the potential role of EBV in pathogenesis: that it is required to contribute to the deregulation of c-myc in the presence of some, but not all, types of c-myc damage arising from the chromosomal translocations.
我们通过Southern印迹法研究了55例伯基特淋巴瘤(BL)的染色体断点位置模式,涉及地理分布和爱泼斯坦-巴尔病毒(EBV)关联情况。我们证实了8号染色体断点与地理分布之间的关联:74%的地方性伯基特淋巴瘤(eBL),但只有9%的散发性伯基特淋巴瘤(sBL)在包含c-myc基因的HindIII片段之外有断点(P2小于0.00001)。相反,91%的sBL显示出HindIII片段重排,而且与17%的eBL病例相比,这些病例中至少56%在c-myc的第一个外显子或内含子内有断点(P2小于0.004)。14号染色体上开关μ(Sμ)区域(即包含Sμ的HindIII片段)之外的断点总体上是Sμ区域内断点(27%)的两倍(73%),但在15个有Sμ断点的肿瘤中,13个(87%)有c-myc基因重排。8号染色体上包含c-myc的HindIII片段之外的断点主要与14号染色体上非Sμ断点相关(85%),这是与eBL最常相关的组合(65%;sBL为6%,P2小于0.00001)。在sBL中,最常见的断点组合是c-myc基因重排与非Sμ断点(63%;eBL为13%)。28%的sBL和13%的eBL在c-myc和Sμ内都有断点。EBV DNA在20个c-myc之外有断点的肿瘤中的19个中存在,在7个c-myc紧邻5'区域有断点的肿瘤中均不存在,在5个第一个外显子有断点的肿瘤中的4个中存在,在12个第一个内含子有断点的肿瘤中的7个中存在。这些数据表明,eBL和sBL的发病机制在c-myc失调机制方面存在差异,可能在恶性转化靶细胞的分化状态方面也存在差异。我们针对EBV在发病机制中的潜在作用提出了一个可检验的假设:即在存在某些(但不是所有)由染色体易位引起的c-myc损伤类型时,它需要促成c-myc的失调。